痤瘡治療市場規模、佔有率和成長分析（按產品、給藥途徑、年齡層、配銷通路和地區）- 2025-2032 年行業預測

2023 年痤瘡治療市場規模價值為 116.2 億美元，預計將從 2024 年的 122.1 億美元成長到 2032 年的 181.8 億美元，預測期內（2025-2032 年）的複合年成長率為 5.1%。

由於尋常性痤瘡（一種影響全球約 9.4% 人口的疾病）的盛行率不斷上升，尤其是在青少年群體中，全球痤瘡治療市場預計將出現顯著成長。造成這一趨勢的因素包括越來越久坐的生活方式、不良的飲食習慣以及越來越偏好微創的美容療程。光是在美國，每年就有 5000 萬人面臨這種皮膚問題，其中 90% 的男性和 80% 的女性在一生中的某個時刻都會經歷痤瘡。然而，對抗生素和類視色素 A等治療藥物的安全性問題對市場擴張構成了挑戰。解決這些問題並滿足不斷成長的需求對於未來的市場相關人員來說可能至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 客戶和購買標準分析
• Start-Ups分析
• 專利分析

痤瘡治療市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 類視色素
• 抗生素
• 異維他命A酸
• 其他

痤瘡治療市場規模（按給藥途徑和複合年成長率） (2025-2032)

• 市場概況
• 口服
• 局部的

痤瘡治療市場規模（按年齡層別分類）及複合年成長率（2025-2032 年）

• 市場概況
• 10 至 17 歲
• 18 至 44 歲
• 45 至 64 歲
• 年齡 65 歲或以上

痤瘡治療市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 醫院藥房
• 零售藥局
• 網路藥局

痤瘡治療市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Ortho Dermatologics（Bausch Health Companies Inc.）（USA）
• GSK plc（UK）
• Bayer AG（Germany）
• Johnson & Johnson Services, Inc.（USA）
• Pfizer Inc.（USA）
• AbbVie Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Botanix Pharmaceuticals（Australia）
• L'Oreal SA（France）
• Clinique Laboratories, LLC（USA）
• Neutrogena（USA）
• Ancalima Lifesciences Ltd.（India）
• Guthy-Renker（USA）
• Murad, Inc.（USA）
• Kose Corporation（Japan）
• Nestle Skin Health（Switzerland）
• Sun Pharmaceutical Industries Ltd.（India）
• Mylan NV（USA）

結論和建議

Acne Treatment Market size was valued at USD 11.62 billion in 2023 and is poised to grow from USD 12.21 billion in 2024 to USD 18.18 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global acne treatment market is poised for significant growth, driven by the increasing prevalence of acne vulgaris-a condition that affects approximately 9.4% of the global population, particularly among adolescents. Factors contributing to this trend include a rise in sedentary lifestyles, poor dietary habits, and a growing preference for less invasive cosmetic treatments. In the U.S. alone, 50 million individuals face this skin condition annually, with 90% of men and 80% of women experiencing acne at some point in their lives. However, the market's expansion is challenged by safety concerns regarding the medications used in treatment, including antibiotics and retinoids. Addressing these concerns while capitalizing on the rising demand will be crucial for market stakeholders moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Treatment Market Segments Analysis

Global Acne Treatment Market is segmented by Product, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Retinoids, Antibiotics, Isotretinoin and Others. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Treatment Market

The global acne treatment market is experiencing significant growth due to the increasing prevalence of skin disorders worldwide. This rise in cases is prompting more patients in regions such as North America, Europe, and Asia Pacific to seek treatment options. Additionally, the emergence of a variety of acne therapies, including retinoids, isotretinoin, and both oral and topical antibiotics, is contributing to heightened awareness of available products and treatments. As patients become more informed about their options, this growing awareness is anticipated to further propel the market's expansion, highlighting the need for effective acne treatments across different demographics.

Restraints in the Acne Treatment Market

The acne treatment market faces several challenges that hinder its growth, despite the widespread occurrence of chronic acne. Notably, a report from the National Center for Biotechnology Information (NCBI) highlights that common side effects associated with antibiotics, such as nausea, vomiting, and diarrhea, affect approximately 7% of patients using tetracyclines and 4% of those on macrolides. Additionally, the U.S. Food and Drug Administration (FDA) has raised concerns about certain over-the-counter (OTC) medications due to their potential to cause severe allergic reactions or significant irritation, further complicating the landscape for effective acne treatment options.

Market Trends of the Acne Treatment Market

The acne treatment market is experiencing a significant shift towards minimally invasive therapies as patient preferences evolve and technological advancements continue. Globally, there is a growing demand for less invasive cosmetic treatments, leading dermatologists to prioritize topical agents and combination therapies over traditional surgical options. Enhanced patient-physician communication and informed decision-making have fueled this trend, as individuals seek effective and less painful solutions for acne management. The rising availability of innovative treatment modalities-paired with improved procedural documentation-further drives the market, positioning minimally invasive techniques as the preferred choice for those seeking effective and convenient acne care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Startup Analysis
• Patent Analysis

Global Acne Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Retinoids
• Antibiotics
• Isotretinoin
• Others

Global Acne Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Topical

Global Acne Treatment Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 10 to 17 Years
• 18 to 44 Years
• 45 to 64 Years
• 65 Years & Above

Global Acne Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Acne Treatment Market Size & CAGR (2025-2032)

• North America (Product, Route of Administration, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Product, Route of Administration, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Ortho Dermatologics (Bausch Health Companies Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Botanix Pharmaceuticals (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L'Oreal S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinique Laboratories, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neutrogena (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ancalima Lifesciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guthy-Renker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Murad, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kose Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Skin Health (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations